首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >An effective model for predicting acute kidney injury after liver transplantation
【24h】

An effective model for predicting acute kidney injury after liver transplantation

机译:预测肝移植后急性肾损伤的有效模型

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Acute kidney injury (AKI) is a common complication in the early period after liver transplantation (LT), posing an enormous obstacle to treatment efifciency and patient survival. However, the exact inlfuencing factors of AKI are still unclear and a predictive model is desperately required in the clinic. METHODS: Data of 102 consecutive LTs were reviewed. A model for predicting AKI was established and further validated in a prospective study of 44 patients receiving LT. RESULTS: The incidence of AKI was 32.4%. AKI patients showed a signiifcantly lower survival rate than non-AKI patients. Multivariate analysis demonstrated the independent inlfuencing factors of AKI were preoperative serum creatinine>1.2 mg/dl, intraoperative urine output≤60 ml/h, intraoperative hypotension status, and intraoperative use of noradrenaline. A model was then established and showed a sensitivity of 75.0%, a speciifcity of 93.8%, and an accuracy of 88.6%in predicting AKI. CONCLUSIONS: High preoperative serum creatinine, low intraoperative urine output, and intraoperative hypotension contribute to the development of AKI, and intraoperative use of noradrenaline serves as a protective factor. The predictive model could potentially facilitate early prediction and surveillance of AKI.
机译:背景:急性肾损伤(AKI)是肝移植(LT)早期的常见并发症,对治疗效率和患者生存构成巨大障碍。但是,AKI的确切影响因素仍不清楚,临床上急需一种预测模型。 方法:对102个连续LT的数据进行了回顾。建立了预测AKI的模型,并在一项针对44名接受LT的患者的前瞻性研究中进一步进行了验证。 结果:AKI的发生率为32.4%。 AKI患者的生存率显着低于非AKI患者。多因素分析表明,AKI的独立影响因素为术前血清肌酐> 1.2 mg / dl,术中尿量≤60ml / h,术中低血压状态以及术中使用去甲肾上腺素。然后建立一个模型,该模型在预测AKI时显示出75.0%的灵敏度,93.8%的特异性以及88.6%的准确性。 结论:pre术前血清肌酐高,术中尿量低,术中低血压是AKI发生的原因,术中使用去甲肾上腺素可作为保护因素。预测模型可以潜在地促进AKI的早期预测和监视。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2010年第003期|259-263|共5页
  • 作者单位

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

    Department of Hepatobiliary and Pancreatic Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China Xu X, Ling Q, Wei Q, Wu J, Gao F, He ZL, Zhou L and Zheng SS;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:39:20
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号